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1. INTRODUCTION 
Besides the active (catalytic) site(s), Fr-ATPase 
has several other nucleotide binding sites (see 
[l-3]). These sites differ in the mode of the nucleo- 
tide binding. Several sites bind the nucleotides 
tightly (nucleotides remain bound to Fr-ATPase 
after gel filtration or repeated precipitation by am- 
monium sulphate). Fr-ATPase cross-linked with 
dimethylsuberimidate can tightly bind 5 ADP 
molecules. This Fr-ATPase preparation containing 
tightly bound nucleotides exhibited ATPase ac- 
tivity [4]. In Fr-ATPase there is also the site (other 
than the active site), which exchanged bound 
nucleotides for the nucleotides of the medium at a 
high rate [3,5,6]. It is possible that this site, which 
is referred to as the non-catalytic in this article, 
may either reversibly or tightly bind nucleotides, 
depending on the ATPase conformation. 
It has been shown that the active site of mito- 
chondrial ATPase is localised on the P-subunit 
[7-121. The results that we obtained using a 
2’,3’-dialdehyde ADP derivative indicate that the 
non-catalytic site of Fr-ATPase is localised on the 
a-subunit [13]. In this study we have investigated 
to what extent 1 ,N6-etheno-adenine nucleotides 
Abbreviations: c-ATP, 1 ,N6-etheno-ATP; E-ADP, 1 ,N6- 
etheno-ADP; E-ATPMC, mixed anhydride of 1,N6- 
etheno-ATP and mesitylene carboxylate; 0x6-ADP, 
2’ ,3’-dialdehyde derivative of 1 ,N6-ethano-ADP 
iodide accessibility 
(bound to the catalytic site, the non-catalytic site 
and to the sites of tight binding) is accessible to 
iodide, a hydrophilic fluorescence quencher. It is 
shown that the 1,N6-etheno-adenine moiety of the 
nucleotide bound to all 3 types of nucleotide 
binding site is accessible to iodide. Thus, in all 3 
cases, the regions of Fr-ATPase that bind the 
adenine moiety of nucleotides are localised on the 
surface of the protein molecule. 
2. MATERIALS AND METHODS 
Fr-ATPase was obtained from beef heart mito- 
chondria according to [14]. The mixed anhydride 
of 1 ,N6-etheno-ATP and mesitylene carboxylate 
(f-ATPMC) was synthesized by Dr N.I. Sokolova 
and Professor Z.A. Shabarova. The 2’,3’-dialde- 
hyde 1,N6-etheno-ADP derivative (oxeADP) was 
obtained from f-ADP (Serva) by periodate oxida- 
tion, according to [15]. For the fluorescence quen- 
ching highly purified KI (Reachim) was used. 
Treatment of Fr-ATPase (2-2.5 mg/ml) with 
2 mM f-ATPMC was carried out for 1 h in 
100 mM Tris-HCI, 0.1 mM EDTA (pH 7.5). For 
the separation of the modified enzyme from the 
free nucleotide a column of Sephadex G-50 fine 
(1 x 25 cm) equilibrated with 10 mM Tris-HCI 
(pH 7.5) was used. The fluorescence measure- 
ments of the modified enzyme were made on a 
Hitachi EPC-3 spectrofluorimeter. The wavelength 
of the exciting light was 320 nm. To determine the 
Published by Elsevier Biomedical Press 
00145793/82/0000-0000/$2.75 0 Federation of European Biochemical Societies 381 
Volume 150, number 2 FEBS LETTERS December 1982 
degree of modification of Fi-ATPase by E-ATPMC, 
the intensity of the fluorescence of the modified 
enzyme at 420 nm was measured (see [16]). The 
stoichiometry of Fi-ATPase/e-ATPMC was 1: 1. 
The treatment of Fi-ATPase with 0x6-ADP was 
done as in [13]. The enzyme was desalted using a 
G-25 Sephadex column (1 x 25 cm), equilibrated 
with 30 mM morpholinopropane sulphonate buf- 
fer, 2 mM EDTA (pH 8.5). The protein solution 
(1 mg/ml) was incubated with 0.3 mM axe-ADP 
for 1.5 h. Two additions of sodium borohydride 
with a 15 min interval were made, up to 2 mM 
final cont. The protein was precipitated by 
ammonium sulphate and dissolved in 10 mM 
Tris-HCl (pH 7.5). Free ox+ADP was removed 
by gel filtration on a Sephadex G-50 fine column. 
Tight E-ADP- and f-ATP-binding to Fi-ATPase 
was studied as in [18]: Fr-ATPase (2-2.5 ml) was 
incubated for 30 min in 100 mM Hepes buffer 
(pH 6.7), 0.25 sucrose, and 3 mM f-ADP or f- 
ATP. Fi-ATPase containing tightly bound nucleo- 
tides was separated from free E-ADP or E-ATP, 
using a column of Sephadex G-50 fine (10 mM 
Tris-HCl, pH 7.5). The stoichiometry of nucleo- 
tide binding was determined by measuring E-ADP 
or c-ATP fluorescence after the release of tightly 
bound nucleotides in the presence of sodium 
dodecyl sulphate. 
3. RESULTS AND DISCUSSION 
The accessibility of the nucleotide binding sites 
of ATPase to hydrophilic ions was studied by 
measuring the fluorescence quenching of bound 
nucleotides by KI. Quenching of the fluorescence 
of etheno-adenine nucleotide by KI is the result of 
the direct contact of iodide ions with the etheno- 
adenine moiety of the nucleotide molecule [ 19,201. 
Fig. 1 (curve 1) shows the dependence of the 
fluorescence intensity of free t-ADP on the KI con- 
centration. A similar picture was obtained for free 
l -ATP (not shown). 
Fig. 1 (curve 2) shows the quenching of the 
fluorescence of etheno-adenine covalently bound 
to the active site of Fi-ATPase as a result of the 
treatment of Fr-ATPase with E-ATPMC. From the 
results obtained it follows that the adenine moiety 
of the nucleotide bound to the ATPase active site 
is only partially (apparently from one side) shielded 
by the protein molecule from the hydrophilic 
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Fig. 1. Fluorescence quenching of free and Fr-ATPase- 
bound etheno nucleotides by KI: curve 1, free ADP 
(8 x lo-’ M); curve 2, F1-ATPase (5 x lo-’ M) treated 
with E-ATPMC; curve 3, Fr-ATPase (2 x lo-’ M) 
treated with 0x6-ADP; curve 4, Fr-ATPase (9 x lo-’ M) 
containing tightly bound ADP (2.7 x lo-’ M); curve 5, 
Fr-ATPase (1.6 x lOme’ M) containing tightly bound 
ATP (8 x lo-’ M). The measurements were made in 
10 mM Tris-HCl buffer (pH 7.5). 
Fig. 2. The fluorescence spectrum of Fr-ATPase treated 
with axe-ADP: curve 1, 10 mM Tris-HCl (pH 7.5); 
curve 2, 10 mM Tris-HCI (PH 7.5), standard preparation 
of Fr-ATPase (3 x lo-’ M); curve 3, 10 mM Tris-HCl 
(pH 7.5) and 3 x lo-’ mM Fr-ATPase treated with 
oxeADP. The wavelength of the exciting light was 
320 nm. 
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iodide ions. Such a situation may occur when the 
region of the adenine binding is located on the sur- 
face of the protein molecule in contact with water. 
As shown elsewhere, oxADP selectively modifies 
the non-catalytic nucleotide binding site of ATPase 
[13]. Here we studied the reaction of Fr-ATPase 
treated with oxf-ADP. Fig. 2 (curve 3) shows the 
fluorescence spectrum of Fr-ATPase treated with 
oxf-ADP. The stoichiometry Fr-ATPase/oxc-ADP 
calculated from the data of fig. 2 is equal to 
0.9-1.0. Similar data on stoichiometry were ob- 
tained in [13], when studying the reaction of 
Fr-ATPase with [3H]oxADP. Fr-ATPase treated 
with oxc-ADP (as well as Fr-ATPase treated with 
oxADP [13]) exhibited full ATPase activity. 
Fig. 1 (curve 3) shows the quenching of the 
fluorescence of etheno-adenine bound to the non- 
catalytic site of Fr-ATPase as a result of treatment 
of the enzyme with exe-ADP. As in the case of the 
active site, the etheno-adenine bound to the non- 
catalytic site of Fr-ATPase is partially accessible to 
the iodide ions. This result testifies to the fact that 
the region of the adenine binding in the non-cata- 
lytic site is located on the surface of the protein 
molecule in direct contact with water. 
We also studied the location of the tight nucleo- 
tide binding sites of Fr-ATPase. According to 
[2,18], the sites of tight nucleotide binding are 
highly specific, thereby c-ADP and c-ATP bind to 
these sites much less easily than ADP and ATP. 
The results obtained in this work show that incuba- 
tion of Fr-ATPase with 3 mM e-ADP or e-ATP at 
pH 6.7 (see section 2) leads to the tight binding 
of 0.3-0.5 mol nucleotides/mol enzyme. Fig. 1 
shows the fluorescence quenching of tightly bound 
ADP (curve 4) and tightly bound f-ATP (curve 5) 
by KI. Control experiments (not shown) indicated 
that 40 mM KI does not lead to the release of 
tightly bound nucleotides from Fr-ATPase. From 
the results obtained it follows that the etheno- 
adenine moiety of the tightly bound nucleotides is 
partially accessible to iodide; i.e., the heterocyclic 
base of the tightly bound nocleotides is located on 
the surface of the Fr-ATPase molecule. This result 
should be regarded as unexpected. In fact, the 
heterocyclic base is the most hydrophobic moiety 
of the nucleotide molecule and might thus be 
assumed to become immersed in the hydrophobic 
pocket of the Fr molecule as a result of tight 
nucleotide binding. The results obtained make us 
think that this is not the case. It is interesting to 
compare this result with our data on the enhance- 
ment of the fluorescence of 2’(3’)-O-trinitro- 
phenyl ADP derivative as a result of tight binding 
of this nucleotide to Fr-ATPase [21]. This fluor- 
escence enhancement testified to the fact that the 
trinitrophenyl residue of tightly bound nucleotides 
is located in the hydrophobic surrounding and thus 
the region of Fr-ATPase responsible for the ribose 
binding is located in the hydrophobic pocket of the 
protein molecule [21]. 
Thus, the tight binding of the nucleotides to 
Fr-ATPase is something of a paradox: the hetero- 
cyclic base binds to the surface of the enzyme, but 
the more hydrophilic ribose residue becomes im- 
mersed in the hydrophobic pocket of the protein 
molecule. 
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